Primary Record
Tavilermide
- In stock
- 4,969 g
- Purity
- 99.0 %
- CAS
- 263251-78-1
Compound Identifiers & Properties
- CAS
- 263251-78-1
- PubChem CID
- 9808372
- SMILES
- C1COC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1C(=O)NCC(=O)O)CCCCN)CCC(=O)O
- Canonical SMILES
- NCCCC[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)c2cc([N+](=O)[O-])ccc2OCC[C@@H](C(=O)NCC(=O)O)NC1=O
Names & Synonyms
- Tavilermide
- tavilermida
- tavilermidum
- MIM-D3
- D 3 (peptide)
- 263251-78-1
- TAVILERMIDE [INN]
- Tavilermide [USAN:INN]
- TAVILERMIDE [USAN]
- UNII-NMG938VJ6T
- RefChem:187555
- NMG938VJ6T
- MIM-D 3
- TAVILERMIDE [WHO-DD]
- orb1706574
- CHEMBL3544981
- SCHEMBL15468298
- SCHEMBL29354556
- DTXSID00180937
- C24H32N6O11
- MFCD30533429
- AKOS040742685
- CID9808372
- CS-7495
- DB12441
- CID 9808372
- DA-78217
- HY-17622
- NS00073403
- J1.239.156K
- G15960
- 3-[(5S,8S,11S)-8-(4-aminobutyl)-5-(carboxymethylcarbamoyl)-16-nitro-7,10,13-trioxo-2-oxa-6,9,12-triazabicyclo[12.4.0]octadeca-1(14),15,17-trien-11-yl]propanoic acid
- A1243929
- Q21098996
- D-3
- 3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1]oxa[5,8,11]triazacyclotetradecin-10-yl)propanoic acid
- 3-(4R,7S,10S)-7-(4-AMINOBUTYL)-4-((CARBOXYMETHYL)AMINO)CARBONYL)-14-NITRO-6,9,12-TRIOXO-3,4,5,6,7,8,9,10,11,12-DECAHYDRO-2H-1,5,8,11-BENZOXATRIAZACYCLOTETRADECIN-10-YL) PROPANOIC ACID
- 3-[(4S,7S,10S)-7-(4-aminobutyl)-4-[(carboxymethyl)carbamoyl]-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-1,5,8,11-benzoxatriazacyclotetradecin-10-yl]propanoic acid
- GLYCINE, N-(2-HYDROXY-5-NITROBENZOYL)-L-.ALPHA.-GLUTAMYL-L-LYSYL-L-HOMOSERYL-, CYCLIC (1->3)-ETHER
- (4S,7S,10S)-2,5,8-Trioxo-7-(4-aminobutyl)-10-[(carboxymethyl)carbamoyl]-17-nitro-13-oxa-3,6,9-triazabicyclo[12.4.0]octadecane-1(14),15,17-triene-4-propionic acid
- (5S,8S,11S)-5-[(2-Hydroxy-2-oxoethyl)carbamoyl]-8-(4-aminobutyl)-11-(3-hydroxy-3-oxopropyl)-16-nitro-2-oxa-6,9,12-triazabicyclo[12.4.0]octadecane-1(14),15,17-triene-7,10,13-trione
- 3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-1,5,8,11-benzoxatriazacyclotetradecin-10-yl)propanoic acid
- 3-((4S,7S,10S)-7-(4-Aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1,5,8,11]oxatriazacyclotetradecin-10-yl)propanoic acid
- 3-{(4S,7S,10S)-7-(4-Aminobutyl)-4-[(carboxymethyl)carbamoyl]-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-1,5,8,11-benzoxatriazacyclotetradecin-10-yl}propanoic acid
- GLYCINE, N-(2-HYDROXY-5-NITROBENZOYL)-L-ALPHA-GLUTAMYL-L-LYSYL-L-HOMOSERYL-, CYCLIC (1->3)-ETHER